KR101081149B1 - Snac(살카프로제이트 나트륨)의 제조 방법 - Google Patents
Snac(살카프로제이트 나트륨)의 제조 방법 Download PDFInfo
- Publication number
- KR101081149B1 KR101081149B1 KR1020097004631A KR20097004631A KR101081149B1 KR 101081149 B1 KR101081149 B1 KR 101081149B1 KR 1020097004631 A KR1020097004631 A KR 1020097004631A KR 20097004631 A KR20097004631 A KR 20097004631A KR 101081149 B1 KR101081149 B1 KR 101081149B1
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- hydroxybenzoyl
- amino
- sodium
- snac
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/10—Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic System
- C07F1/04—Sodium compounds
Abstract
Description
Claims (9)
- 2,4-다이옥소-1,3-벤즈옥사진일옥탄산 에틸 에스터를 수산화 나트륨, 물, 및 에틸렌다이아민 테트라아세트산, 아스코르브산, NaHSO3 및 트라이페닐포스파인으로 이루어진 군으로부터 선택된 성분과 혼합함으로써 2,4-다이옥소-1,3-벤즈옥사진일옥탄산 에틸 에스터를 가수분해시키는 단계를 포함하는, N-(8-[2-하이드록시벤조일]-아미노) 카프릴산의 합성 방법.
- 2,4-다이옥소-1,3-벤즈옥사진일옥탄산 에틸 에스터를 수산화 나트륨 및 미리 비등된 물과 혼합함으로써 2,4-다이옥소-1,3-벤즈옥사진일옥탄산 에틸 에스터를 가수분해시키는 단계를 포함하는, N-(8-[2-하이드록시벤조일]-아미노) 카프릴산의 합성 방법.
- 제 1 항에 있어서,수산화 나트륨, 물, 및 에틸렌다이아민 테트라아세트산, 아스코르브산, NaHSO3 및 트라이페닐포스파인으로 이루어진 군으로부터 선택된 성분과 혼합된 2,4-다이옥소-1,3-벤즈옥사진일옥탄산 에틸 에스터를, 아세톤 및 염산과 혼합하는 단계를 추가로 포함하는, 합성 방법.
- 제 2 항에 있어서,수산화 나트륨 및 미리 비등된 물과 혼합된 2,4-다이옥소-1,3-벤즈옥사진일옥탄산 에틸 에스터에, 아세톤 및 염산을 첨가하는 단계를 추가로 포함하는, 합성 방법.
- 2-프로판올 중에 현탁된 N-(8-[2-하이드록시벤조일]-아미노) 카프릴산을 수산화 나트륨 수용액과 혼합하여 N-(8-[2-하이드록시벤조일]-아미노) 카프릴산 나트륨 염의 용액을 형성하는 단계를 포함하는, N-(8-[2-하이드록시벤조일]-아미노) 카프릴산 나트륨 염의 합성 방법.
- 제 5 항에 있어서,추가의 2-프로판올을 N-(8-[2-하이드록시벤조일]-아미노) 카프릴산 나트륨 염의 용액에 첨가하는 단계; 상기 용액을 결정성 N-(8-[2-하이드록시벤조일]-아미노) 카프릴산 나트륨 염으로 시딩(seeding)하여 상기 N-(8-[2-하이드록시벤조일]-아미노) 카프릴산 나트륨 염을 상기 용액으로부터 침전시키는 단계; 및 이어서, 추가의 2-프로판올을 상기 용액에 첨가하는 단계를 추가로 포함하는, 합성 방법.
- 제 6 항에 있어서,결정성 N-(8-[2-하이드록시벤조일]-아미노) 카프릴산 나트륨 염이 무수 N-(8-[2-하이드록시벤조일]-아미노) 카프릴산 나트륨 염인, 합성 방법.
- 삭제
- 삭제
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84277506P | 2006-09-07 | 2006-09-07 | |
US60/842,775 | 2006-09-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090060997A KR20090060997A (ko) | 2009-06-15 |
KR101081149B1 true KR101081149B1 (ko) | 2011-11-07 |
Family
ID=38702068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097004631A KR101081149B1 (ko) | 2006-09-07 | 2007-08-30 | Snac(살카프로제이트 나트륨)의 제조 방법 |
Country Status (12)
Country | Link |
---|---|
US (3) | US7544833B2 (ko) |
EP (1) | EP2064175B1 (ko) |
JP (1) | JP5021033B2 (ko) |
KR (1) | KR101081149B1 (ko) |
CN (1) | CN101506147B (ko) |
AU (1) | AU2007293916B2 (ko) |
BR (1) | BRPI0716539A2 (ko) |
CA (1) | CA2662080C (ko) |
ES (1) | ES2498519T3 (ko) |
IL (1) | IL197014A (ko) |
MX (1) | MX2009002121A (ko) |
WO (1) | WO2008028859A1 (ko) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2662853C (en) * | 2006-08-31 | 2016-07-26 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
CA2662080C (en) * | 2006-09-07 | 2012-07-17 | F. Hoffmann-La Roche Ag | A process for the manufacture of snac (salcaprozate sodium) |
DK3326620T3 (da) | 2010-12-16 | 2020-05-25 | Novo Nordisk As | Faste sammensætninger omfattende en glp-1-agonist og et salt af n-(8-(2- hydroxybenzoyl)amino)caprylsyre |
MX355361B (es) | 2011-04-12 | 2018-04-17 | Novo Nordisk As | Derivados de peptido 1 tipo glucagon (glp-1) doblemente acilados. |
AU2013234496B2 (en) | 2012-03-22 | 2017-07-27 | Novo Nordisk A/S | Compositions of GLP-1 peptides and preparation thereof |
EP4331667A2 (en) | 2012-03-22 | 2024-03-06 | Novo Nordisk A/S | Compositions comprising a delivery agent and preparation thereof |
HUE042757T2 (hu) | 2012-03-22 | 2019-07-29 | Novo Nordisk As | Szállító szert tartalmazó készítmények és elõállításuk |
ES2871328T3 (es) | 2012-06-20 | 2021-10-28 | Novo Nordisk As | Formulación de comprimido que comprende un péptido y un agente de suministro |
RU2671406C2 (ru) | 2013-05-02 | 2018-10-31 | Ново Нордиск А/С | Пероральная дозированная форма соединений глюкагоноподобного пептида-1 |
DK3241878T4 (da) * | 2014-09-25 | 2024-02-05 | Daikin Ind Ltd | Sammensætning, der omfatter hfc og hfo |
CN105566141B (zh) * | 2015-12-17 | 2018-01-26 | 蚌埠丰原医药科技发展有限公司 | 一种门冬氨酸缩合物的制备方法 |
AR112015A1 (es) | 2017-06-09 | 2019-09-11 | Novo Nordisk As | Composiciones sólidas para administración oral |
MA49617A (fr) | 2017-07-19 | 2020-05-27 | Novo Nordisk As | Analogues d'egf(a), préparation, formulations et utilisations associées |
IL275778B2 (en) | 2018-02-02 | 2023-12-01 | Novo Nordisk As | Solid compounds that make up glp-1 agonist n-8-2-hydroxybenzoyl salt |
TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
CN108689876B (zh) * | 2018-06-28 | 2020-11-27 | 苏州东南药业股份有限公司 | 一种8-(2-羟基苯甲酰胺基)辛酸钠的制备方法 |
AU2020326265A1 (en) | 2019-08-07 | 2022-02-03 | Novo Nordisk A/S | Solid compositions comprising an EGF(A) derivative and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid |
WO2021043971A1 (en) | 2019-09-06 | 2021-03-11 | Novo Nordisk A/S | Method and equipment for fractionation of granules for use in pharmaceutical compositions |
BR112022007721A2 (pt) | 2019-11-06 | 2022-07-12 | Novo Nordisk As | Método para o tratamento da demência |
IL291893A (en) | 2019-11-07 | 2022-06-01 | Novo Nordisk As | Solid preparations comprising a pcsk9 inhibitor and a salt of n-(8-(2-hydroxybenzoyl)amino) caprylic acid |
US20220395559A1 (en) | 2019-11-07 | 2022-12-15 | Novo Nordisk A/S | Solid compositions comprising a glp-1 agonist, an sglt2 inhibitor and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid |
IT202000003251A1 (it) | 2020-02-18 | 2021-08-18 | Dipharma Francis Srl | Preparazione di un analgesico non steroideo |
US11478533B2 (en) | 2020-04-27 | 2022-10-25 | Novo Nordisk A/S | Semaglutide for use in medicine |
JP2023524695A (ja) | 2020-04-29 | 2023-06-13 | ノヴォ ノルディスク アー/エス | Glp-1作動薬およびヒスチジンを含む固形組成物 |
CN113735734B (zh) * | 2020-05-29 | 2023-12-08 | 杭州先为达生物科技股份有限公司 | N-[8-(2-羟基苯甲酰基)氨基]辛酸钾晶体多晶型物及其制备方法和用途 |
JP2023527238A (ja) | 2020-05-29 | 2023-06-27 | 杭州先▲為▼▲達▼生物科技有限公司 | N-[8-(2-ヒドロキシベンゾイル)アミノ]オクタン酸カリウム結晶多形ならびにその調製方法及び使用 |
JPWO2022080294A1 (ko) | 2020-10-16 | 2022-04-21 | ||
WO2022162132A1 (en) | 2021-01-29 | 2022-08-04 | Novo Nordisk A/S | Novel synthesis of salcaprozic acid by amide formation |
EP4323330A1 (en) | 2021-04-16 | 2024-02-21 | Navinta III Inc | Process for the preparation of highly pure salcaprozic acid and pharmaceutically acceptable salts thereof |
US11667614B2 (en) | 2021-04-16 | 2023-06-06 | Navinta III Inc. | Process for the preparation of highly pure Salcaprozic Acid and pharmaceutically acceptable salts thereof |
CR20230471A (es) | 2021-04-22 | 2023-11-01 | Civi Biopharma Inc | Administración oral de oligonucleótidos |
WO2022264166A1 (en) | 2021-06-14 | 2022-12-22 | Mylan Laboratories Limited | Process for the preparation of pure salcaprozate sodium |
EP4360645A1 (en) | 2021-06-25 | 2024-05-01 | Gan & Lee Pharmaceuticals Co., Ltd. | Pharmaceutical composition containing glp-1 compound |
WO2023285580A1 (en) | 2021-07-15 | 2023-01-19 | Novo Nordisk A/S | Tablet comprising a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid |
CA3223247A1 (en) | 2021-07-16 | 2023-01-19 | Thomas Kvistgaard Vilhelmsen | Sodium n-(8-(2- hydroxybenzoyl)amino)caprylate polymorphic form a |
WO2023012263A1 (en) | 2021-08-04 | 2023-02-09 | Novo Nordisk A/S | Solid oral peptide formulations |
CN115108936A (zh) * | 2022-07-29 | 2022-09-27 | 成都普康唯新生物科技有限公司 | 无水体系制备8-(2-羟基苯甲酰胺基)辛酸钠无水晶型的方法 |
CN115160178A (zh) * | 2022-07-29 | 2022-10-11 | 成都普康唯新生物科技有限公司 | 一种8-(2-羟基苯甲酰胺基)辛酸钠无水晶型的制备方法 |
CN117466765B (zh) * | 2023-12-27 | 2024-03-15 | 成都道合尔医药技术有限公司 | 8-(2-羟基苯甲酰胺基)辛酸钠及其合成方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000046182A1 (en) | 1999-02-05 | 2000-08-10 | Emisphere Technologies, Inc. | Method of preparing alkylated salicylamides |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3840570A (en) * | 1970-12-07 | 1974-10-08 | Procter & Gamble | Process for preparing sterols from tall oil pitch |
DE3623397A1 (de) | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
US5717109A (en) | 1994-09-08 | 1998-02-10 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
US5650386A (en) | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
GB2320248B (en) | 1995-09-11 | 1999-04-14 | Emisphere Tech Inc | Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones |
JPH09188661A (ja) * | 1996-01-10 | 1997-07-22 | Kao Corp | ポリオキシアルキレン脂肪酸アミド硫酸エステル塩の製造方法 |
US6096273A (en) | 1996-11-05 | 2000-08-01 | Clinical Micro Sensors | Electrodes linked via conductive oligomers to nucleic acids |
US7381525B1 (en) | 1997-03-07 | 2008-06-03 | Clinical Micro Sensors, Inc. | AC/DC voltage apparatus for detection of nucleic acids |
US7393645B2 (en) | 1996-11-05 | 2008-07-01 | Clinical Micro Sensors, Inc. | Compositions for the electronic detection of analytes utilizing monolayers |
AU4400997A (en) | 1997-09-18 | 1999-04-05 | Hyundai Pharm. Ind. Co., Ltd. | Process for the preparation of calcitonin |
CA2369591C (en) * | 1999-04-05 | 2011-06-14 | Emisphere Technologies, Inc. | Disodium salts, monohydrate, and ethanol solvates |
US6492408B1 (en) | 1999-07-21 | 2002-12-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
ES2386263T3 (es) | 2000-03-21 | 2012-08-14 | Emisphere Technologies, Inc. | Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato |
US7262325B2 (en) | 2000-06-02 | 2007-08-28 | Emisphere Technologies, Inc. | Method of preparing salicylamides |
US6949577B2 (en) | 2000-09-13 | 2005-09-27 | Pfizer, Inc. | Pharmaceuticals |
GB0107924D0 (en) | 2001-03-29 | 2001-05-23 | Angeletti P Ist Richerche Bio | Inhibitor of hepatitis C virus NS3 protease |
ATE409187T1 (de) | 2002-03-15 | 2008-10-15 | Merck & Co Inc | N-(substituierte benzyl)-8-hydroxy-1,6- naphthyridin-7- carbonsäureamide als hiv- integrase-hemmer |
US20060173046A1 (en) | 2003-07-15 | 2006-08-03 | Bell Ian M | Hydroxypyridine cgrp receptor antagonists |
US7524813B2 (en) | 2003-10-10 | 2009-04-28 | Novo Nordisk Health Care Ag | Selectively conjugated peptides and methods of making the same |
JP2005298463A (ja) * | 2004-04-07 | 2005-10-27 | Matsumoto Yushi Seiyaku Co Ltd | 開環重合方法 |
EP1773351B1 (en) | 2004-05-06 | 2019-04-24 | Emisphere Technologies, Inc. | Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate |
PE20060653A1 (es) | 2004-08-31 | 2006-09-27 | Glaxo Group Ltd | Derivados triciclicos condensados como moduladores del receptor 5-ht1 |
JP5011683B2 (ja) * | 2004-09-06 | 2012-08-29 | Dic株式会社 | 多価ヒドロキシ化合物、エポキシ樹脂、及びそれらの製造法、エポキシ樹脂組成物と硬化物 |
CA2592092A1 (en) | 2004-12-22 | 2006-06-29 | Pfizer Limited | Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
WO2006103686A1 (en) | 2005-03-29 | 2006-10-05 | Hetero Drugs Limited | An improved process for the preparation of cefixime |
WO2007068474A1 (en) | 2005-12-14 | 2007-06-21 | Medivir Ab | (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors |
US8217177B2 (en) | 2006-07-14 | 2012-07-10 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
US8198448B2 (en) | 2006-07-14 | 2012-06-12 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
PE20080403A1 (es) | 2006-07-14 | 2008-04-25 | Amgen Inc | Derivados heterociclicos fusionados y metodos de uso |
CA2662080C (en) * | 2006-09-07 | 2012-07-17 | F. Hoffmann-La Roche Ag | A process for the manufacture of snac (salcaprozate sodium) |
FR2912145B1 (fr) | 2007-02-02 | 2009-03-06 | Servier Lab | Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
EP2167477B1 (en) | 2007-06-27 | 2013-02-27 | Mylan Laboratories Limited | Process for preparing pure valsartan |
SG183068A1 (en) | 2007-07-31 | 2012-08-30 | Otsuka Chemical Co Ltd | Method for producing peptide |
CN101367750B (zh) | 2007-08-14 | 2012-05-23 | 中国人民解放军军事医学科学院毒物药物研究所 | (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途 |
-
2007
- 2007-08-30 CA CA2662080A patent/CA2662080C/en not_active Expired - Fee Related
- 2007-08-30 ES ES07803046.7T patent/ES2498519T3/es active Active
- 2007-08-30 BR BRPI0716539A patent/BRPI0716539A2/pt not_active Application Discontinuation
- 2007-08-30 WO PCT/EP2007/059037 patent/WO2008028859A1/en active Application Filing
- 2007-08-30 US US11/847,415 patent/US7544833B2/en active Active
- 2007-08-30 KR KR1020097004631A patent/KR101081149B1/ko active IP Right Grant
- 2007-08-30 AU AU2007293916A patent/AU2007293916B2/en active Active
- 2007-08-30 US US16/490,424 patent/US10875826B2/en active Active
- 2007-08-30 MX MX2009002121A patent/MX2009002121A/es active IP Right Grant
- 2007-08-30 EP EP07803046.7A patent/EP2064175B1/en active Active
- 2007-08-30 CN CN2007800316394A patent/CN101506147B/zh active Active
- 2007-08-30 JP JP2009527117A patent/JP5021033B2/ja active Active
-
2009
- 2009-02-12 IL IL197014A patent/IL197014A/en active IP Right Grant
-
2020
- 2020-11-23 US US17/101,375 patent/US20210070691A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000046182A1 (en) | 1999-02-05 | 2000-08-10 | Emisphere Technologies, Inc. | Method of preparing alkylated salicylamides |
Also Published As
Publication number | Publication date |
---|---|
CA2662080C (en) | 2012-07-17 |
MX2009002121A (es) | 2009-05-20 |
WO2008028859A1 (en) | 2008-03-13 |
ES2498519T3 (es) | 2014-09-24 |
JP5021033B2 (ja) | 2012-09-05 |
US20080064890A1 (en) | 2008-03-13 |
KR20090060997A (ko) | 2009-06-15 |
IL197014A (en) | 2013-01-31 |
US7544833B2 (en) | 2009-06-09 |
BRPI0716539A2 (pt) | 2016-11-01 |
CN101506147B (zh) | 2012-03-21 |
US10875826B2 (en) | 2020-12-29 |
CN101506147A (zh) | 2009-08-12 |
CA2662080A1 (en) | 2008-03-13 |
JP2010502667A (ja) | 2010-01-28 |
US20210070691A1 (en) | 2021-03-11 |
AU2007293916A1 (en) | 2008-03-13 |
US20200071263A1 (en) | 2020-03-05 |
EP2064175B1 (en) | 2014-08-06 |
IL197014A0 (en) | 2009-11-18 |
EP2064175A1 (en) | 2009-06-03 |
AU2007293916B2 (en) | 2011-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101081149B1 (ko) | Snac(살카프로제이트 나트륨)의 제조 방법 | |
JP6932227B2 (ja) | カルビドパおよびl−ドーパプロドラッグならびにそれらの使用方法 | |
WO2018096504A1 (en) | Cbd prodrugs, compositions, and methods of administering cbd and cbd prodrugs | |
EP1131327B1 (en) | Prostaglandin conjugates for treating or preventing bone diseases | |
SK11002002A3 (sk) | Proces na selektívnu produkciu hemipentahydrátu monohydrátu sodnej soli kyseliny 3-pyridyl-1-hydroxyetylidén-1,1- bifosfónovej a farmaceutický prostriedok | |
CZ304038B6 (cs) | Zpusob výroby geminálních bisfosfonátu | |
US20210323908A1 (en) | Process for producing tca cycle intermediate conjugates | |
ES2278297T3 (es) | Utilizacion de derivados de 2-amino-2h-quinazolina para la produccion de agentes terapeuticos. | |
TW202024038A (zh) | 靶向突變哺乳動物蛋白質之小分子 | |
WO2022020247A1 (en) | Small molecule correctors of mammalian slc6a8 function | |
WO2020061476A1 (en) | Small molecules targeting mutant mammalian proteins | |
EP3315493B1 (en) | Phenyl amino pyrimidine compound or polymorph of salt thereof | |
WO2009061336A1 (en) | Amorphous and crystalline forms of ibandronate disodium | |
WO2007082472A1 (en) | Anti-infective quinolone compound, preparation method thereof and use thereof | |
WO2001030788A1 (en) | Novel salts of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20141030 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150930 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20161028 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170929 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180928 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190924 Year of fee payment: 9 |